SCHEMBL7445531

SCHEMBL7445531

CCCN(C(=O)c1ccccc1)C1Cc2cccc(N)c2C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.41
KCNH2 Q12809 1/20 0.41
DRD3 P35462 4/20 0.40
HTR1A P08908 3/20 0.40
HTR7 P34969 3/20 0.40
DRD2 P14416 5/20 0.40
DRD4 P21917 3/20 0.40
DRD1 P21728 3/20 0.40
DRD5 P21918 1/20 0.40
ADRB2 P07550 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7442930 0.86 DRD3 (0.54) SLC6A4KCNH2DRD3HTR1A
SCHEMBL7443025 0.84 DRD3 (0.42) DRD3HTR1AHTR7DRD2DRD4
SCHEMBL7447925 0.82 ALDH1A1 (0.40) SLC6A4KCNH2DRD3HTR1AHTR7
SCHEMBL7444816 0.80 SLC6A4 (0.44) SLC6A4KCNH2DRD3DRD2
SCHEMBL7437479 0.76 DRD3 (0.65) DRD3HTR1AHTR7DRD2DRD4
SCHEMBL13434159 0.76 SLC6A4 (0.58) SLC6A4KCNH2
SCHEMBL13911241 0.75 SLC6A4 (0.56) SLC6A4KCNH2
SCHEMBL7335068 0.74 DRD2 (0.51) DRD3HTR1AHTR7DRD2DRD4
SCHEMBL13911269 0.72 AGER (0.56) SLC6A4KCNH2
SCHEMBL7442254 0.71 ALDH1A1 (0.46) SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5639778-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1997-06-17 US disclosed
EP-0690843-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY PHARMACIA & UPJOHN COMPANY (US) 1996-01-10 EP disclosed
WO-1994021608-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY THE UPJOHN COMPANY (US) 1994-09-29 WO disclosed